Healthcare -
Biotechnology - NASDAQ - US
$ 26.5
0.607 %
$ 2.22 B
Market Cap
-5.79
P/E
BEAM - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BEAM - Beam Therapeutics Inc.
276 M
LAST VALUE
-39.53%
2 YEAR CAGR
8.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR